Senescence monitoring requires the recruitment and maturation of CCR2 bone marrow cells, while CCR2 ablation induces HCC growth. In contrast, HCC cells inhibit the maturation of recruited myeloid precursors, which promote mouse HCC growth and deteriorate the prognosis and survival of human HCC patients by inhibiting NK cells. This evidence concerns the gene CCR2 and hepatocellular carcinoma.